DiaSorin receives clearance from the CE Notified Body to market the LIAISON XL Murex Anti-HDV assay for the diagnosis of Hepatitis D virus (HDV) infection enlarging its CLIA menu for hepatitis on LIAISON platforms. HDV is the infectious agent causing hepatitis D that requires HBV for transmission and it is considered to be the most severe form of viral hepatitis in humans. Chronic HDV infection leads to a severe liver disease and is associated with accelerated fibrosis progression, earlier hepatic decompensation and an increased risk for the development of hepatocellular carcinoma.
For more information:
http://www.diasorin.com/sites/default/files/allegati_pressrel/pr_diasorin_hdv.pdf